India’s Pharma Sector Breathes Easy as Trump Spares Generic Drugs from Tariffs The Indian pharmaceutical industry, known for its cost-effective generic formulations, has dodged a significant bullet as the U.S. government has chosen to keep pharma imports exempt from newly announced reciprocal tariffs. This development has come as a sigh of relief for domestic drug...